Sofosbuvir & Ledipasvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Sofosbuvir 400 mg & Ledipasvir 90 mg
Reference Brands: Harvoni®(EU & US)
Category: Anti Viral
Sofosbuvir & Ledipasvir Tablets (400/90 mg) treat Hepatitis C with high cure rates. Available under brands like Harvoni®, Ledifos®, and Hepcinat-LP®, they can be bulk-sourced via PharmaB2B platforms from WHO-GMP-approved manufacturers for tenders, NGOs, and HCV treatment programs worldwide. Sofosbuvir & Ledipasvir is available in Tablet and strengths such as Sofosbuvir 400 mg & Ledipasvir 90 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sofosbuvir & Ledipasvir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sofosbuvir & Ledipasvir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Sofosbuvir & Ledipasvir Tablets (400 mg/90 mg) are a powerful, once-daily combination therapy for chronic Hepatitis C. Marketed under global brands like Harvoni®, Ledifos®, and Hepcinat-LP®, this fixed-dose antiviral regimen is recommended by WHO and major liver associations. It offers high cure rates with minimal side effects across genotypes 1, 4, 5, and 6. On PharmaB2B platforms, global buyers can source WHO-GMP and USFDA-approved generic alternatives from trusted Indian manufacturers. Ideal for institutional procurement, NGO supply, and public health programs, Sofosbuvir + Ledipasvir helps scale access to life-saving HCV treatment worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sofosbuvir & Ledipasvir is used for the treatment of chronic hepatitis C virus (HCV) infection, mainly genotype 1, 4, 5, and 6. It helps reduce viral load and supports complete viral clearance with sustained virologic response.
It is made from the active ingredients sofosbuvir, an NS5B polymerase inhibitor, and ledipasvir, an NS5A inhibitor. Together they block HCV replication and viral assembly.
The primary trade name is Harvoni in the USA, EU, and UK, along with multiple licensed generics available in India and other regions.
Harvoni is manufactured by Gilead Sciences. Several licensed generic manufacturers in India and other countries also produce approved generic versions.
The generic name is sofosbuvir & ledipasvir.
The main brand name is Harvoni, with various licensed generic brand names depending on the region.
It is manufactured by Gilead Sciences in the USA and by licensed generic manufacturers in India and other global regions.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View Details
Raltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
